a year ago

Tagomics Secures £6.7M Series A Funding Led by Calculus Capital

  • Tagomics, a Cambridge, UK-based developer of a platform for comprehensive disease insight and diagnosis, raised £6.7M in Series A funding led by Calculus Capital, with participation from Illumina Ventures, IQ Capital, Agilent Ventures, Mercia Ventures, MEIF Proof of Concept & Early Stage Fund, Meltwind and OMX Ventures

  • This follows a £1.6M pre-seed round led by IQ Capital and Start Codon and including grant funding from Innovate UK

  • The company intends to use the funds to accelerate its scientific research and product development, with the goal of delivering improvements in cancer and other diseases’ diagnosis and treatment

  • Tagomics has developed a platform that combines “omics” technologies, including genomics, epigenomics, and fragmentomics, to help discover new markers of cancer and develop strategic partnerships, advancing drug development and therapy selection for patients.

      • ProblemHealthcare

      "making cancer diagnosis and treatment more accurate and efficient"

      Solution

      "integrating various 'omics' technologies and using advanced data analysis and machine learning to discover new markers of cancer and develop better diagnostic tools and treatment strategies"

      Covered on